“…In both these models, the neutrophil infiltration into the inflamed tissues was significantly reduced by the administration of IS-741. It has also been reported that this new agent decreased the number of adherent leukocytes along pancreatic collecting venules, as well as reducing the expression of Mac-1 (CD11b/CD18) on circulating neutrophils, in an acute pancreatitis model, 15 and it also decreased the number of neutrophils and Mac-1-positive cells accumulated in the injured lung. 17 Based on these results, it appears that the leukocyte accumulation during the early phase of pancreatitis and lung injury may be mediated by leukocyte-endothelial cell interactions via the leukocyte integrin Mac-1, and that this new anti-inflammatory agent attenuated the leukocyteendothelial interactions as a consequence of its inhibitory effect on Mac-1 expression in the inflamed lesions.…”